Compare CORT & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | GSAT |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.7B |
| IPO Year | 2001 | 2006 |
| Metric | CORT | GSAT |
|---|---|---|
| Price | $113.79 | $82.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $96.50 | $70.50 |
| AVG Volume (30 Days) | ★ 823.3K | 538.0K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.58 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $761,407,000.00 | $112,660,000.00 |
| Revenue This Year | $26.08 | $10.31 |
| Revenue Next Year | $26.98 | $15.93 |
| P/E Ratio | $1,224.56 | ★ N/A |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $33.90 |
| 52 Week High | $126.38 | $84.85 |
| Indicator | CORT | GSAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 60.13 |
| Support Level | $108.25 | $80.90 |
| Resistance Level | $124.30 | $84.77 |
| Average True Range (ATR) | 5.29 | 0.56 |
| MACD | -0.76 | 0.08 |
| Stochastic Oscillator | 61.04 | 93.47 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.